Asthma Trial - PowerPoint PPT Presentation

1 / 8
About This Presentation
Title:

Asthma Trial

Description:

Asthma Trial a double blinded, randomized, placebo-controlled study Team Moser: Jing Dong Yan Yan Wu Haipeng Yao Purpose The new puffer is effective or not Target ... – PowerPoint PPT presentation

Number of Views:67
Avg rating:3.0/5.0
Slides: 9
Provided by: MSUs86
Category:
Tags: asthama | asthma | trial

less

Transcript and Presenter's Notes

Title: Asthma Trial


1
Asthma Trial a double blinded, randomized,
placebo-controlled study
  • Team Moser
  • Jing Dong
  • Yan Yan Wu
  • Haipeng Yao

2
  • Purpose
  • The new puffer is effective or not
  • Target population
  • Physician-diagnosed severe asthma patients

3
Objectives and Endpoints
  • Primary objective the new puffer is effective
    or not
  • Primary endpoint the measurement of FEV1
  • Secondary objective
  • - if the puffer is effective for patients of
    different age group
  • - if the puffer will reduce symptoms of
    different severity levels
  • Secondary endpoint
  • - record the numbers of Hospitalization,
    emergency visits, the use of
  • rescue medication etc
  • Rescue medication is allowed in this
    trial. And the of the use of rescue
  • medication will be one of the measures of
    the secondary endpoint

4
Evaluation designA double blinded, randomized,
placebo-controlled study
  • 1. Control
  • - Intervention Group patients take the
    new puffer twice a day for 12
  • weeks and record FEV1 weekly.
  • - Control Group patients take
    placebo puffer twice a day for 12
  • weeks and record FEV1 weekly
  • 12 weeks later, all patients visit
    physician and physician diagnose if the puffer is
    effective based on the FEV1 value
  • The type of design is superiority because
    our goal is that the treatment if more effective
    than placebo

5
  • Randomization
  • Sample size
  • a0.05 ß1- power(0.8) 0.2
    (Za1.645, Zß1.28)
  • Assume effective rate of the
    intervention group (Pi ) 0.4
  • effective rate of the
    placebo group (Pc) 0.2
  • 2N 2
    126
  • Randomize
  • Assign trial subject to intervention or
    control group using computer-generated
  • randomization with 50-50 chance for each
    group for a total of 126 patients
  • Double - Blind
  • Both patients and physician are unaware of
    treatment assignment

6
Drop - outs
  • complete analysis
  • P effective case / N
  • weighting method
  • P effective case / N drop outs
  • imputation method
  • - LOCF (Last Observation Carry Forward)
  • incomplete case analysis
  • - Analyze the odds ratio of drop-outs in
    different groups
  • - Use regression analysis to analyze the
    reasons of drop outs

7
Repeated Measures- Pre-post treatment on the
same observation
8
Statistical Analysis
  • 1. Pi Pc 0.2 (difference in proportion)
  • 2. ? gt 2 ( ? odds ratio)
Write a Comment
User Comments (0)
About PowerShow.com